| Attribute |
Value |
| 52 Week Change |
-0.90657896 |
| Address1 |
21 Business Park Drive |
| All Time High |
1,036.0 |
| All Time Low |
0.1 |
| Ask |
0.13 |
| Ask Size |
4,500 |
| Average Daily Volume10 Day |
1,867,950 |
| Average Daily Volume3 Month |
11,645,022 |
| Average Volume |
11,645,022 |
| Average Volume10Days |
1,867,950 |
| Beta |
-1.205 |
| Bid |
0.0 |
| Bid Size |
1,100 |
| Book Value |
0.647 |
| City |
Branford |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.1301 |
| Current Ratio |
6.943 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
0.142 |
| Day Low |
0.1295 |
| Debt To Equity |
3.276 |
| Display Name |
Azitra |
| Ebitda |
-11,658,645 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
0.652 |
| Enterprise Value |
-7,601,037 |
| Eps Forward |
-0.52 |
| Eps Trailing Twelve Months |
-0.87 |
| Esg Populated |
0 |
| Exchange |
ASE |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.2033 |
| Fifty Day Average Change |
-0.0732 |
| Fifty Day Average Change Percent |
-0.36005905 |
| Fifty Two Week Change Percent |
-90.6579 |
| Fifty Two Week High |
1.62 |
| Fifty Two Week High Change |
-1.4899 |
| Fifty Two Week High Change Percent |
-0.9196913 |
| Fifty Two Week Low |
0.1 |
| Fifty Two Week Low Change |
0.030099995 |
| Fifty Two Week Low Change Percent |
0.30099994 |
| Fifty Two Week Range |
0.1 - 1.62 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,686,922,200,000 |
| Float Shares |
12,126,517 |
| Forward Eps |
-0.52 |
| Forward P E |
-0.2501923 |
| Free Cashflow |
-6,696,973 |
| Full Exchange Name |
NYSE American |
| Full Time Employees |
13 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.28419 |
| Held Percent Institutions |
0.06271 |
| Implied Shares Outstanding |
16,192,438 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,755,734,400 |
| Last Split Factor |
15:100 |
| Long Business Summary |
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut. |
| Long Name |
Azitra, Inc. |
| Market |
us_market |
| Market Cap |
2,106,636 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_404021170 |
| Most Recent Quarter |
1,774,915,200 |
| Name Change Date |
2,026-07-13 |
| Net Income To Common |
-11,814,265 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
2,106,636 |
| Number Of Analyst Opinions |
2 |
| Open |
0.14 |
| Operating Cashflow |
-10,629,667 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
203 646 6446 |
| Pre Market Change |
-0.0032000095 |
| Pre Market Change Percent |
-2.431618 |
| Pre Market Price |
0.1284 |
| Pre Market Time |
1,784,023,450 |
| Prev Name |
Azitra Inc |
| Previous Close |
0.142 |
| Price Hint |
4 |
| Price To Book |
0.2010819 |
| Profit Margins |
0.0 |
| Quick Ratio |
6.585 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.0119 |
| Regular Market Change Percent |
-8.38029 |
| Regular Market Day High |
0.142 |
| Regular Market Day Low |
0.1295 |
| Regular Market Day Range |
0.1295 - 0.142 |
| Regular Market Open |
0.14 |
| Regular Market Previous Close |
0.142 |
| Regular Market Price |
0.1301 |
| Regular Market Time |
1,783,972,800 |
| Regular Market Volume |
1,812,272 |
| Return On Assets |
-0.81789 |
| Return On Equity |
-1.5871 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
16,192,438 |
| Shares Percent Shares Out |
0.0172 |
| Shares Short |
278,208 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
61,636 |
| Short Name |
Azitra Inc |
| Short Percent Of Float |
0.026300002 |
| Short Ratio |
0.01 |
| Source Interval |
15 |
| State |
CT |
| Symbol |
AZTR |
| Target High Price |
1.0 |
| Target Low Price |
0.55 |
| Target Mean Price |
0.775 |
| Target Median Price |
0.775 |
| Total Cash |
10,051,003 |
| Total Cash Per Share |
0.621 |
| Total Debt |
343,330 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.87 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
0.310425 |
| Two Hundred Day Average Change |
-0.18032502 |
| Two Hundred Day Average Change Percent |
-0.5808972 |
| Type Disp |
Equity |
| Volume |
1,812,272 |
| Website |
https://azitrainc.com |
| Zip |
6,405 |